Levetiracetam Versus Valproate in Idiopathic Generalized Epilepsy
NCT ID: NCT06393309
Last Updated: 2024-05-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
169 participants
OBSERVATIONAL
2022-09-03
2024-03-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Levetiracetam Versus Valproate in Idiopathic Generalized Tonic-clonic Seizures
NCT03940326
Cognitive Effects of Treatment of Interictal Discharges
NCT00916149
Levetiracetam Versus Sodium Valproate in Children With Refractory Generalized Convulsive Status Epilepticus
NCT02920060
Evaluate Retention Rate of Topiramate, Levetiracetam and Oxcarbazepine in a Long-term Epilepsy Treatment
NCT02098941
Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subjects With Newly or Recently Diagnosed Partial Epilepsy
NCT01498822
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Levetiracetam
Patients with idiopathic generalized epilepsy who were under treatment with levetiracetam
Levetiracetam
Patients with idiopathic generalized epilepsy who were under treatment with levetiracetam
Sodium valproate
Patients with idiopathic generalized epilepsy who were under treatment with valproate
Sodium valproate
Patients with idiopathic generalized epilepsy who were under treatment with valproate
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Levetiracetam
Patients with idiopathic generalized epilepsy who were under treatment with levetiracetam
Sodium valproate
Patients with idiopathic generalized epilepsy who were under treatment with valproate
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Regular monotherapy with levetiracetam or sodium valproate
Exclusion Criteria
* Pregnancy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mazandaran University of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nasim Tabrizi
Associate professor of neurology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bu Ali Sina Hospital
Sari, Mazandaran, Iran
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14751
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.